A study analysing incidences of herpesvirus reactivation after BNT162b2 vaccination
Latest Information Update: 13 Sep 2021
Price :
$35 *
At a glance
- Drugs Tozinameran (Primary)
- Indications COVID-19 respiratory infection
- Focus Adverse reactions
- 13 Sep 2021 New trial record
- 30 Aug 2021 Results published in the Vaccine